Sleep and tolerability of extended release dexmethylphenidate [Focalin XR] vs. mixed amphetamine salts [Adderall XR]: a double blind, placebo controlled study (SAT STUDY).

Trial Profile

Sleep and tolerability of extended release dexmethylphenidate [Focalin XR] vs. mixed amphetamine salts [Adderall XR]: a double blind, placebo controlled study (SAT STUDY).

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Apr 2017

At a glance

  • Drugs Dexmethylphenidate (Primary) ; Mixed amfetamine salts
  • Indications Attention-deficit hyperactivity disorder
  • Focus Adverse reactions
  • Acronyms SAT
  • Most Recent Events

    • 01 Dec 2011 Results published in the Journal of Child and Adolescent Psychopharmacology.
    • 04 May 2010 Results were presented at the Annual Meeting of the Pediatric American Societies 2010.
    • 11 Aug 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top